Nuveen Asset Management, LLC Adicet Bio, Inc. Transaction History

Nuveen Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.76 - $3.45 $381,624 - $748,070	216,832 Added 111.88%	410,636 $964,000
Q4 2023 Feb 14, 2024	BUY	$1.11 - $1.89 $34,423 - $58,612	31,012 Added 19.05%	193,804 $366,000
Q3 2023 Nov 14, 2023	SELL	$1.37 - $3.4 $1,320 - $3,277	-964 Reduced 0.59%	162,792 $223,000
Q2 2023 Aug 14, 2023	BUY	$2.13 - $7.13 $147,121 - $492,476	69,071 Added 72.95%	163,756 $397,000
Q1 2023 May 15, 2023	SELL	$5.52 - $9.23 $29,399 - $49,158	-5,326 Reduced 5.33%	94,685 $545,000
Q4 2022 Feb 14, 2023	SELL	$7.72 - $21.27 $99,140 - $273,149	-12,842 Reduced 11.38%	100,011 $894,000
Q3 2022 Nov 14, 2022	BUY	$13.43 - $18.74 $93,795 - $130,880	6,984 Added 6.6%	112,853 $1.61 Million
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $249,030 - $505,100	24,272 Added 29.75%	105,869 $1.55 Million
Q1 2022 May 16, 2022	BUY	$11.53 - $19.97 $331,833 - $574,736	28,780 Added 54.49%	81,597 $1.23 Million
Q4 2021 Feb 14, 2022	SELL	$7.37 - $17.49 $95,139 - $225,778	-12,909 Reduced 19.64%	52,817 $750,000
Q3 2021 Nov 12, 2021	BUY	$6.29 - $9.93 $22,826 - $36,035	3,629 Added 5.84%	65,726 $473,000
Q2 2021 Aug 16, 2021	BUY	$9.19 - $15.93 $570,671 - $989,205	62,097 New	62,097 $639,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.